Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 1Phase 1 1

Status

Recruiting 3Active not recruiting 3Completed 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 7Genitourinary 1

Conditions

Breast Neoplasms 5Neoplasm Metastasis 2Vaginitis 1Triple Negative Breast Neoplasms 1Estrogen Receptor Positive Breast Cancer 1Atrophic Vaginitis 1Anatomic Stage III Breast Cancer AJCC v8 1

Interventions

Paclitaxel 161Fulvestrant 155Trastuzumab 152pembrolizumab 144Letrozole 136Carboplatin 118pertuzumab 104Cyclophosphamide 102Capecitabine 102Specimen Handling 101Anastrozole 90palbociclib 85abemaciclib 81Magnetic Resonance Spectroscopy 81exemestane 76Docetaxel 76Tamoxifen 75ribociclib 73trastuzumab deruxtecan 69Radiotherapy 61Biopsy 59Surveys and Questionnaires 56Gemcitabine 52130-nm albumin-bound paclitaxel 52sacituzumab govitecan 50olaparib 50Standard of Care 49Blood Specimen Collection 49Taxes 47Doxorubicin 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Estradiol × Breast × 1 year × Clear all
NCT03941730 2026-05-12

Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer

Mayo Clinic

Phase 2 Active not recruiting
8 enrolled 9 charts
Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05716516 2026-05-05

ESTHER

Dartmouth-Hitchcock Medical Center

Phase 2 Recruiting
36 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT06179303 2026-04-16

Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer

University of Washington

Phase 2 Recruiting
60 enrolled
Breast

Anatomic Stage III Breast Cancer AJCC v8

NCT01984138 2026-01-28

REVIVE

The Methodist Hospital Research Institute

Phase 2 Active not recruiting
33 enrolled
Breast

Breast Neoplasms

NCT00984399 2025-12-09

Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen

Memorial Sloan Kettering Cancer Center

Phase NA Completed
31 enrolled 12 charts
Breast

Breast Neoplasms, Vaginitis, Atrophic Vaginitis

NCT05900895 2025-11-20

PHOEBE

Dartmouth-Hitchcock Medical Center

Phase 1 Recruiting
6 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02238808 2025-06-26

PRESTO

AHS Cancer Control Alberta

Phase 2 Active not recruiting
19 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡